BioLineRx : FORM S-8-registration of Ordinary Shares to be issued under the Plan -December 31, 2023 at 03:01 am EST

As filed with the Securities and Exchange Commission on December 29, 2023.


Registration No. 333-


UNITED STATES


...

Related Keywords

Modiin ,Israel General ,Israel ,Washington ,United States ,New York ,Massachusetts ,Tel Aviv ,Waltham ,Israeli ,State Of Israel ,American ,Sharon Rosen ,Raphael Hofstein ,Adamd Janoff ,Avraham Molcho ,Phil Serlin ,Shaoyu Yan ,Philipa Serlin ,Kesselman ,Gal Cohen ,Michaelj Anghel ,Aharon Schwartz ,Gary Emmanuel ,Company The Board ,Securities Exchange ,Company The ,Biolinerx Ltd ,Pricewaterhousecoopers International ,Company Adss ,Exchange Commission ,Greenberg Traurig ,Company American Depositary ,Israel The Company ,Exchange Commission On ,Biolinerx United States Inc ,Exact Name ,Ma Ayan Street ,Incentive Plan ,Linerx United States ,Begin Street ,Post Effective Amendment ,Registration Statements ,Ordinary Shares ,Prior Registration ,Prior Registration Statements ,Securities Exchange Act ,Annual Report ,Securities Act ,Exchange Act ,Corporate Secretary ,Certified Public Accountants ,Coopers International Limited ,Registration Statement ,Mali Ze Evi ,Executive Officer ,Principal Executive Officer ,Mali Zeevi ,Principal Financial ,Accounting Officer ,Rami Dar ,Sandra Panem ,Authorized Person ,American Depositary Shares ,Deposit Agreement ,New York Mellon ,Public Accountants ,Pricewaterhousecoopers International Limited ,Filing Fee Tables ,Form Type ,Newly Registered Securities ,American Depositary Receipts ,Nasdaq Capital Market ,Ordinary Share ,Markets ,